Cancer patients receiving treatment may mount inadequate immune response to COVID-19 vaccination

By | January 21, 2022
A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy – and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells – may mount an inadequate immune response to COVID-19 vaccination.